Advances in Biological Regulation
- Label
- Advances in Biological Regulation (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (Prodotto della ricerca)
- Diverse roles of GSK-3: Tumor promoter-tumor suppressor, target in cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear PI-PLCbeta1: An appraisal on targets and pathology (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Alternative label
- Advances in Biological Regulation (literal)
- Language
- eng (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn
- 2212-4926 (literal)
- Preferred label
- Advances in Biological Regulation (literal)
- Publisher
- Elsevier Amsterdam NLD (literal)
Incoming links:
- Rivista
- Diverse roles of GSK-3: Tumor promoter-tumor suppressor, target in cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (Prodotto della ricerca)
- Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear PI-PLCbeta1: An appraisal on targets and pathology (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
